ArticleFrontiers in oncology2025
Metastatic squamous cell carcinoma of mediastinal lymph nodes from the ileum: a case report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mediastinal lymph node metastasis from squamous cell carcinoma (SCC) is one of the most common sites for regional metastasis in thoracic malignancies. However, SCC originating from the ileum is relatively rare. We herein report a case of mediastinal lymph node metastasis as the first manifestation of postoperative ileal SCC. No primary tumor was detected on comprehensive imaging studies and bronchoscopy in this patient, and endobronchial ultrasound (E-BUS) considered metastatic SCC. After undergoing four cycles of postoperative chemotherapy with the XELOX regimen, the patient experienced rapid disease progression; however, a subsequent change to a treatment regimen of paclitaxel and cisplatin resulted in a favorable response. This article details the patient's clinical presentation and treatment course and includes a literature review of primary SCCs arising from the jejunum and ileum, thereby enhancing understanding of these uncommon small intestine tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.